Xiaoyun Liao, M Click here .D., Ph.D., Paul Lochhead, M.B., Ch.B., Reiko Nishihara, Ph.D., Teppei Morikawa, M.D., Ph.D., Aya Kuchiba, Ph.D., Mai Yamauchi, Ph.D., Yu Imamura, M.D., Ph.D., Zhi Rong Qian, M.D., Ph.D., Yoshifumi Baba, M.D., Ph.D., Kaori Shima, D.D.S., Ph.D., Ruifang Sun, M.B., Katsuhiko Nosho, M.D., Ph.D., Jeffrey A. Meyerhardt, M.D., M.P.H., Edward Giovannucci, M.D., M.P.H., Sc.D., Charles S. Fuchs, M.D., M.P.H., Andrew T. Chan, M.D., M.P.H., and Shuji Ogino, M.D., Ph.D.: Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival Numerous observational and randomized, controlled studies have suggested a defensive effect of regular usage of aspirin in colorectal neoplasias.1-7 The favorable outcome that is associated with aspirin use following colorectal cancer is diagnosed8-10 shows that aspirin is a promising agent for adjuvant therapy.
Second, letting the market form usability assumes that clinicians will be the focus on users. So EHRs will be just as good as the product quality metrics they’re made to catch; technology can’t conquer fundamental measurement problems. We measure a lot of things that have no worth to patients, while much of what individuals do worth, including our attention, remains unmeasurable. Why, Wachter asks, perform we do nothing identical in health care? In a moving passage, Wachter speaks with a famous surgeon who once spent his evenings before surgery reading his notes on another day’s patients. No longer. His notes have been rendered uselessly homogeneous by the tyranny of clicks and auto-populated fields.